Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of ORal Bacterial EXtract for the Prevention of Wheezing Lower Respiratory Tract Illness (ORBEX)

NCT02148796 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT02148796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02148796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of ORal Bacterial EXtract for the Prevention of Wheezing Lower Respiratory Tract Illness (ORBEX)
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2017
Completion date
January 30, 2026
Enrollment
822 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, wheezing